Id |
Subject |
Object |
Predicate |
Lexical cue |
SS1_21486442_0_0 |
25-54 |
expanded |
denotes |
Relative Total Dose Intensity |
SS2_21486442_0_0 |
56-60 |
abbr |
denotes |
RTDI |
SS1_21486442_2_0 |
258-287 |
expanded |
denotes |
relative total dose intensity |
SS2_21486442_2_0 |
289-293 |
abbr |
denotes |
RTDI |
SS1_21486442_2_1 |
342-366 |
expanded |
denotes |
metastatic breast cancer |
SS2_21486442_2_1 |
368-371 |
abbr |
denotes |
MBC |
SS1_21486442_6_0 |
613-640 |
expanded |
denotes |
time to disease progression |
SS2_21486442_6_0 |
642-646 |
abbr |
denotes |
TTDP |
SS1_21486442_6_1 |
652-668 |
expanded |
denotes |
overall survival |
SS2_21486442_6_1 |
670-672 |
abbr |
denotes |
OS |
SS1_21486442_9_0 |
972-999 |
expanded |
denotes |
primary disease progression |
SS2_21486442_9_0 |
1001-1004 |
abbr |
denotes |
PDP |
AE1_21486442_0_0 |
SS1_21486442_0_0 |
SS2_21486442_0_0 |
abbreviatedTo |
Relative Total Dose Intensity,RTDI |
AE1_21486442_2_0 |
SS1_21486442_2_0 |
SS2_21486442_2_0 |
abbreviatedTo |
relative total dose intensity,RTDI |
AE1_21486442_2_1 |
SS1_21486442_2_1 |
SS2_21486442_2_1 |
abbreviatedTo |
metastatic breast cancer,MBC |
AE1_21486442_6_0 |
SS1_21486442_6_0 |
SS2_21486442_6_0 |
abbreviatedTo |
time to disease progression,TTDP |
AE1_21486442_6_1 |
SS1_21486442_6_1 |
SS2_21486442_6_1 |
abbreviatedTo |
overall survival,OS |
AE1_21486442_9_0 |
SS1_21486442_9_0 |
SS2_21486442_9_0 |
abbreviatedTo |
primary disease progression,PDP |